A novel one-stage procedure where definitive implants are combined with a collagen matrix is compared to the traditional two-staged procedure where a tissue expander is placed before an implant. Our hypotheses are the following:The use of a collagen…
ID
Source
Brief title
Condition
- Other condition
- Breast therapeutic procedures
Synonym
Health condition
Borstreconstructies.
Research involving
Sponsors and support
Intervention
Outcome measures
Primary outcome
The primary endpoint of the study is the quality of life as measured by a
specific breast related questionnaire (BREAST-Q) pre-operative and at one year
after placement of the permanent prosthesis. This questionnaire was elected
because it is especially suitable and valid for the post-mastectomy population.
In addition measure sexual health with questionaires before surgery and 12
months after surgery. Complication rate (e.g. infection, implant loss, seroma,
contraction of the breast), aesthetic outcome (as measured by a panel of
experts at one year after placement of the permanent prosthesis), pain, and
patient burden with regard to the number of procedures and time invested are
secondary outcomes. In addition, we look at cost-effectiveness. The esthetic
outcome will be scored from pictures pre-operatively and one year
post-operatively following the four point Harris breast scale
(excellent-good-fair-poor) by the patient and a surgeonspanel.
Secondary outcome
Secondly we look at the cost-effectiveness of the procedures. The
cost-effectiveness using the Dutch tariff QALYs will be calculated based on the
EQ-5D.
Background summary
Psychological outcome greatly improves when immediate breast reconstruction is
performed after mastectomy. The traditional method for breast reconstruction
after skin sparing mastectomy is a two-stage procedure where tissue expanders
are used as a first step and definitive implants are placed in a second
procedure. Each surgical procedure involves patient discomfort, multiple times
of tissue expander filling, health risks and costs. It is advantageous if
immediate breast reconstruction can be performed in a single procedure. Several
direct implant one-stage procedures are known. They either provide full muscle
coverage, with the disadvantage of high placement of prosthesis, needing
revision surgery, or they provide poor coverage in the lower portion of the
prosthesis. The use of a collagen matrix- an innovative approach in the
one-stage operation technique - solves this problem. The technique involves
insetting a sheet of collagen matrix between the infra mammary fold and the
inferior border of the pectoralis major which leads to precise control of the
inframammary fold, breast shape and lateral breast border. This results in a
complete coverage of the implant without resorting to additional muscle or
fascial elevation and better esthetical outcome. Collagen matrix can
successfully be used in conjunction with breast implants to achieve an
aesthetically pleasing result in one stage primary breast reconstruction,
providing good soft tissue cover at the time after. The use of a tissue
expander and its associated risks and costs are eliminated.
Study objective
A novel one-stage procedure where definitive implants are combined with a
collagen matrix is compared to the traditional two-staged procedure where a
tissue expander is placed before an implant.
Our hypotheses are the following:
The use of a collagen matrix in combination with definitive implants in
immediate breast reconstruction after skin sparing mastectomy is a good
one-stage alternative for the traditional two-stage procedure because we think
it
1. Has the same or a lower complication rate.
2. Gives equal or a better cosmetic result.
3. Is less painful to the patient.
4. Is more cost-effective.
Study design
The study is a prospective multicenter, single blinded, randomized controlled
clinical outcomes study. Randomization is stratified for all centers and
divided over time in blocks. A statistician will prepare the randomization in
advance. Before the operation is planned randomization takes place with closed
numbered envelopes. Four academic centers and three peripheral hospitals in
the Netherlands will participate coordinated by the principle investigator.
Intervention
1. Two stage breast reconstruction after skin sparing mastectomy, with placing
of a tissue expander in the first, and implantation of a breast implant in the
second stage.
2. One stage immediate breast reconstruction where implants are combined with a
collagen matrix inlay.
Study burden and risks
The risk of complications will be comparable too the normal procedures. The
extra burden for the patient includes the completion of questionnaires at each
visit. The great benefit of participating in his study is that patients will be
monitored closely and therefore the surgeon can follow the post-operative time
closely. The big incentive for participating on the study is that women can
finish their treatment earlier and hopefully with a better esthetical outcome
only when randomized in the one stage procedure. The rest of the patients will
receive the standard surgical treatment and after care for their condition.
De Boelelaan 1117
Amsterdam 1081 HV
NL
De Boelelaan 1117
Amsterdam 1081 HV
NL
Listed location countries
Age
Inclusion criteria
Female patients from the participating hospitals are included if they meet the following criteria: willing and able to participate; aged 18 and over; able to provide informed consent and to complete questionnaires. Women who meet the inclusion criteria are informed about the study by their doctor and recieve a patientletter. There will be the possibility to ask further questions. Patients are included after signing the informed consent.
Exclusion criteria
Exclusion criteria are: pregnancy or planning a pregnancy during the study; ongoing severe psychiatric illness or mental retardation; evidence of alcohol and/or drug abuse; inability to complete the questionnaires; local or general infection which could jeopardize the surgical objective; extensive local inflammatory reactions; proven or suspected hypersensitivity to materials; immunosuppressive pathologies
Design
Recruitment
Followed up by the following (possibly more current) registration
No registrations found.
Other (possibly less up-to-date) registrations in this register
No registrations found.
In other registers
Register | ID |
---|---|
CCMO | NL41125.029.12 |